Research News

Research News | Apr. 17, 2018

New Study Seeks to Determine Effectiveness of Synthetic Cannabinoid in Relieving Joint Pain in Lupus

A new clinical trial is underway to test the efficacy efficacy of a synthetic cannabinoid derivative for joint pain.

Research News | Feb. 07, 2018

Atacicept Study Data Shows Promising Results

Results from a Phase IIb 24-week clinical trial show that Atacicect is safe and may benefit people with high levels of disease activity.

Research News | Dec. 22, 2017

Major Lupus Stem Cell Study Receives Funding

$3.8 million committed by the Lupus Foundation of America to support first-of-its-kind research.

Research News | Nov. 06, 2017

Lupus Investigators Receive Prestigious Awards for Valuable Contributions in Research

Dr. Rosalind Ramsey-Goldman and Dr. José Crispín are recognized by the Lupus Foundation of America for their achievements in lupus research.

Research News | Nov. 05, 2017

Study Leads to a New Approach for Evaluating the Effectiveness of Experimental Therapies

Research News | Nov. 04, 2017

Study Reveals Shockingly High Rates of Incorrect Lupus Diagnosis

A Lupus Foundation of America study finds almost 50% of adults with lupus are misdiagnosed at the start of their journey.

Research News | Sep. 11, 2017

Lupus Impacts Asian/Pacific Islanders and Hispanics at Alarming Rates

New population-based analyses measure incidence and prevalence of lupus among these fast growing U.S. populations.

Research News | Jul. 21, 2017

FDA Approves BENLYSTA as a Weekly Self-Administered Injection to Treat Lupus

Benlysta SC is the first self-injection lupus treatment that can administered at home once per week.